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Abstract 
The Mascarene Aloes are used in the traditional pharmacopoeia against various ailments 
including cutaneous diseases and as antispasmodics. Scientific evidence to support these claims 
is non-existent and mainly based on the scientific repute of A. vera. The antioxidant profile of 
methanolic leaf extracts of A. purpurea Lam., A. tormentorii (Marais) L. E. Newton & G. D. 
Rowley, A. lomatophylloides Balf.f., A. macra Haw. and A. vera (L.) Burm.f. was studied using 
the Total Antioxidant Capacity, Copper Equivalent and Superoxide Dismutase assays. In vitro 
cytotoxicity was evaluated on CAD (Cath. - differentiated) neuronal cells by the MTT (methyl 
tetrazolium) assay and the neuroprotective profile was assessed using hydrogen peroxide-
induced neurotoxicity with the CAD cells. The aloin and vitexin content were determined by 
High-performance liquid chromatography with diode-array detection . A. purpurea had the 
highest aloin content (546.6 nmol/g), while A. tormentorii had the highest vitexin content (67.3 
nmol/g). A. macra (concentration < 0.1 mg/ml) elicited a 10% cytotoxicity effect on CAD cells 
while other Mascarene Aloes were not cytotoxic. This study validates the antioxidant and 
neuroprotective potential of Mascarene Aloes focusing on their aloin and vitexin content which 
are also present in other reputed medicinal Aloes. 
 
Keywords: Mascarene Aloes, antioxidant, neuroprotection, aloin, vitexin. 
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Introduction  
The Mascarene Aloes are comprised of A. tormentorii (Marais) L.E Newton & G.D Rowley 
and A. purpurea Lam. which are endemic to Mauritius (Marais et al., 1978; Gurib-Fakim, 
2003), as well as A. macra Haw. endemic to Réunion Island and A. lomatophylloides Balf.f 
native to Rodrigues (Bosser et al., 1976; Marais et al., 1978; Pailler et al., 2000). A. purpurea 
from Reunion has been reported as being a putative hybrid of A. macra and A. tormentorii 
(Ranghoo-Sanmukhiya et al., 2010). The indigenous Mascarene Aloes are extensively used in 
the Mauritian pharmacopoeia to treat cutaneous bacterial infections and boils, and as 
antispasmodic medications to relieve stomach pains (Gurib-Fakim, 2003). Various extracts of 
Aloe species are traditionally and commercially used for both cosmetic and medicinal purposes 
with very little scientific evidence to support these claims, since they are mostly based on 
research performed on A. vera (L.) Burm. f.  
Mauritius is experiencing a high prevalence of chronic diseases of the circulatory system and 
non-communicable diseases among its population. Biochemical, physiological and 
pharmacological data have revealed that oxidative stress is implicated in the pathology of many 
diseases, for example cardiovascular tissue injury (Neergheen et al., 2010), diabetes and 
dementia (Williams et al., 2011; Howes and Simmonds, 2014). There has been an increased 
interest and engagement of researchers in evaluating local herbs and medicinal plants in the 
quest for novel sources of antioxidants and neuroprotectants.   
 
The anthraquinone profiles of Mascarene Aloes have been previously described (Ranghoo-
Sanmukhiya et al., 2010.  In addition several authors have described the anti-oxidant capacity 
of A. vera (Hu et al., 2003; Saada et al., 2003; Saritha et al., 2010; Lee et al., 2012; 
Padmanabhan and Jangle, 2012).  
Several plants already have a proven track record for central nervous system activities, 
including lemon balm (Melissa officinalis L.), lavender (Lavandula angustifolia Mill.), ginseng 
(Panax ginseng C.A.Mey.), saffron (Crocus sativus L.) and valerian (Valeriana officinalis L.) 
(Abuhamdah and Chazot, 2008; Perry and Howes, 2010) and it is possible that there are further 
such neuroactives still to be found from nature. A survey carried out by (Grace et al., 2008) 
referred to the traditional use of an Aloe species against a nervous system disorder namely the 
use of a leaf decoction of Aloe asperifolia A. Berger as an ailment for epilepsy. A. vera has 
also been reported to be a therapeutic against Alzheimer’s disease and depression, glaucoma, 
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among others (Foster et al., 2011). Such traditional uses indicate prospective antioxidant and 
neuroprotective properties in the Aloe family of plants. However, to date, the neuroprotective 
attributes of Mascarene Aloes have not yet been reported. There are many challenges with the 
use of plants for medicinal applications and a major issue is the correct authentication of species 
medicinally, whilst ensuring that the correct plant part is also used. Furthermore, it is important 
to chemically characterise the plant preparations used pharmacologically and clinically, since 
considerable variation can occur in phytochemical profiles. Whilst these issues have been 
addressed for many herbal medicine preparations (Howes and Simmonds, 2015), there remain 
many issues with the identity and composition of plant preparations used as medicines. An 
additional concern is the use or overexploitation of species that are endangered. This is a 
particular issue for the genus Aloe, and species are included in the Appendices for the 
Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES, 
2015) and the International Union for Conservation of Nature (IUCN, 2015) Red List of 
Threatened Species.  
 
This study aims to evaluate the antioxidant activity, cytotoxicity and neuroprotective properties 
of Mascarene Aloes in an attempt to validate, for the first time, their potential as a source 
therapeutics for neuropharmacological applications (as well as epilepsy), setting the scene for 
their future sustainable cultivation and use. 
 
Material and Methods 
Plant material 
Leaves from five-year old plants of A. purpurea, A. tormentorii, A. lomatophylloides, A. macra 
and A. vera were obtained from the National Parks and Conservation Service (Mauritius) and 
Mauritius Herbarium garden, MSIRI. A voucher specimen of each Mascarene Aloe species: A. 
purpurea (Mauritius)-MAU 0014447; A. tormentorii- MAU 0014094; A. lomatophylloides- 
MAU 0014095; A. macra- WV 99110; A. purpurea (originating from Réunion Island)- WS 
99067, was deposited at the herbarium of the Mauritius Sugar Industry Research Institute 
(Réduit, Mauritius). The leaves were lyophilised and stored in air-tight bottles. Genetic data 
(not shown) and chemical profiles were determined to support the botanical identification of 
the respective Aloe species (Govinden-Soulange et al., 2017). 
Methods 
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 Metabolite extraction 
Lyophilised leaf samples (100 mg) of each Mascarene Aloe species were suspended in 10 mL 
of cold 70% (v/v) methanol, heated under reflux at 60 ºC for 1 hr, sonicated for 15 min and 
centrifuged for 10 min at 5000 resolutions per min (rpm). The supernatant was filtered (0.45 
mm filter) and analysed. For bioassays, the extracts were concentrated by leaving to air dry and 
the residues were resuspended in 10% (v/v) ethanol and stored at -20°C in aliquots. For all the 
experiments, dilutions of extracts were performed fresh using a starting concentration of 
1mg/ml on the day of the bioassay. 
 
 High Performance-Liquid Chromatography (HPLC) Analysis 
The HPLC analyses were performed using a Waters Acquity H-Class UPLC system.  The 
HPLC operating conditions were as follows: The column was a Waters Acquity BEH C18 (1.7 
µm, 100 mm x 2.1mm) and the solvent system constituted of (A) 10 mM ammonium phosphate 
(pH 3.0) with methanesulfonic acid and (B) acetonitrile at a flow rate of 0.4 mL/min; the 
column temperature was 40°C. Initial mobile phase conditions were 5% B, increased to 15% 
B over 3 min, with a linear increase to 45% B after 12 min. The column was washed with 
100% B for 1 min and allowed to re-equilibrate to the starting conditions, giving a run time of 
20 min. Detection was achieved by diode array detector and data were extracted at 260 and 
340 nm. Data analysis was performed using Empower 3 software (Waters). The HPLC profiles 
of A. purpurea (Mauritius and Réunion), A. tormentorii, A. lomatophylloides and A. macra 
were compared with that of A. vera. Compounds were assigned by comparison with the 
reference compounds vitexin (AApin Chemicals Limited, UK) and aloin (AApin Chemicals 
Limited, UK), and by comparison with published UV spectra (Da Graça Campos and 
Markham, 2007). Calibration curves were constructed at a concentration ranging from 0.1mg 
to 10mg/ml following HPLC analysis (as described above) of the reference compounds (aloin 
and vitexin) to determine the quantities of these compounds in each of the Aloe samples, based 
on peak area. 
 
Total Antioxidant Capacity (TAC) Assay 
The OxiSelect™ Total Antioxidant Capacity (TAC) Assay Kit (Cell Biolabs, USA) measures 
the total antioxidant capacity of biomolecules from a variety of samples via a SET mechanism. 
In the presence of anti-oxidants, copper (II) is reduced to copper(I). In turn, the copper(I) ions 
react with a chromogen to produce a colour with maximum absorbance at 490nm. Various 
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concentrations of Aloe crude extracts (0.1, 0.01, 0.001 and 0.0001 mg/ml) were evaluated for 
the total anti-oxidant capacity. The anti-oxidant capacity is determined by comparison with 
uric acid standards and expressed in millimoles. 
 
Total anti-oxidant capacity (Trolox) assay 
This assay measures both reactive oxygen and nitrogen species. The Cayman's (Cayman 
Chemical Company, USA) anti-oxidant assay relies on the ability of anti-oxidant to inhibit 
oxidation of ABTS and is quantified as millimolar TROLOX equivalents. The amount of 
ABTS+ is monitored by absorbance at 405nm. The tested concentrations of the Aloe extracts 
are 0.1, 0.01, 0.001 and 0.0001 mg/ml, respectively. 
 
CAD cell culture 
CAD (Cath.-a-differentiated) cultures were grown at 37°C and in 5% CO2 on 75 cm
2 tissue 
culture flasks (Sarstedt, Newton, NC) in Dulbecco's modified eagles' medium DMEM⁄F-12 
Media - GlutaMAX™-I (GIBCO, Grand Island, NY), supplemented with 10% foetal bovine 
serum (FBS; Sigma, St. Louis, MO, USA). Cells were passaged every 6–7 days at a 1:4 dilution 
(Abuhamdah et al., 2015). 
 
Superoxide Dimutase Assay on CAD cells  
Undifferentiated and 6 days differentiated CAD cells seeded in 6-well plates were treated with 
0.1 mg/ml extract for 24 h and incubated at 37°C and 5% CO2. After centrifugation at 200 × g 
for 5 min at 4 °C, the pellet was re-suspended in 100µl of 20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer, pH 7.2 containing 1mM ethylene glycol 
tetraacetic acid (EGTA), 210 mM Mannitol and 70 mM sucrose and frozen until further use. 
The supernatant was evaluated for SOD1 activity using a SOD activity assay kit (Cayman 
Chemicals Inc., Ann Arbor, Michigan) according to the manufacturer's protocol. Nitro blue 
tetrazolium (NBT) salt was used to quantify superoxide radicals generated by xanthine oxidase 
and hypoxanthine. All treatments were performed in triplicates. 
 
Treatment of cell cultures with hydrogen peroxide and Aloe extracts 
Hydrogen peroxide (H2O2)-induced insult with a series of increasing concentrations was 
performed to determine the dose-dependent effects on CAD cell survival as described by 
(Abuhamdah et al., 2015). A series of concentrations of H2O2 were prepared from a fresh stock 
(2500µm) into Dulbecco's modified eagles' medium DMEM⁄F-12 Media - GlutaMAX™-I 
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supplemented with 10% FBS to achieve final concentrations of 250 µM, 200 µM, 150 µM, 100 
µM and 50 µM. Subconfluent cultures (70–80%) were dislodged by gentle pipetting; 
transferred and centrifuged at 200 × g for 5 min at 4 °C. The pellet was then re-suspended in 
DMEM/F-12 Media GlutaMAX-I supplemented with 10% FBS and immediately plated in 24-
well plates and incubated at 37°C and 5% CO2. After 24 h, the media were replaced with media 
containing the different H2O2 concentrations prepared earlier and grown in culture for further 
24 h after which an 3-[4,5- dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) 
assay was performed. The effect of Aloe extracts concentrations was initially investigated by 
applying different concentrations (0.0001, 0.001, 0.01, 0.1mg/ml) for 24h to CAD cell cultures. 
The cell viability was assayed using a standard MTT assay (Freshney, 2001; Abuhamdah et 
al., 2015) . 
 
Preconditioning and Neuroprotection study 
Survival of CAD cells was assessed after 24 h pretreatment with Aloe extracts (0.01 and 0.1 
mg/ml (w/v) followed by 24 h post-treatment with 250 μm H2O2 (i.e. Aloe extracts containing 
media removed before addition of H2O2 - preconditioning protocol). A second set of 
experiments were performed when the Aloe extracts containing media was not removed prior 
to exposure to the H2O2 – neuroprotection method). All the treatments were performed in 
triplicates. 
MTT Cell Proliferation Assay 
The tetrazolium dye MTT (Sigma, UK) was used to assess cell viability as described by 
Abuhamdah et al., (2015). 50 microliters Phosphate buffered saline (PBS) (PBS) (136.9 mm 
2.68 mm KCl, 4.3 mm Na2HPO4, 1.4 mm KH2PO4, pH 7.4) containing a final concentration of 
5 mg/ml MTT was added to the cultures and incubated at 37°C and in 5% CO2 for 2.5 h. The 
MTT containing medium was then removed and the surface of the wells was rinsed gently with 
300 µl PBS before the application of 250 µL isopropanol. The optical density of 100 µL 
samples was spectrophotometrically read at 595 nm (Thermo Labsystems Multiskan Ascent, 
V1.3). 
 
 
Statistical Analysis  
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All the experiments were performed in replicates (n= 3 - 4) and statistical analysis was carried 
out using one-way ANOVA as the data was normal. Tukey’s test was performed using SPSS 
16.0. The values of p < 0.05 were considered to be statistically significant.  
 
Results 
HPLC analysis 
Evaluation of the aloin content showed that A. purpurea originating from Réunion Island was 
approximately three-fold higher in aloin content (546.6 nmol/g) compared to the other Aloe 
species, except for A. lomatophylloides, in which the aloin content was almost ten-fold lower 
and A. macra, in which aloin was not detected. Vitexin was detected in all the Aloe species 
under study, with the highest concentration in A. tormentorii (67.3 nmol/g) and the lowest (12.6 
nmol/g) in A. vera (Table 1). 
 
Antioxidant capacity of the Aloe extracts 
The antioxidant activities of the methanolic Aloe extracts based on Trolox and TAC (copper 
reducing equivalent) are shown in Table 2. The scavenging potential of the Aloe extracts 
assayed by the TEAC method varied between 0.35mM and 0.55mM compared to Trolox 
equivalents, with A. vera exhibiting the highest activity (0.55 mM), followed by A. 
lomatophylloides. A. purpurea (Réunion Island) and A. macra were characterised with high 
copper-reducing activity with a value of 0.643 ± 0.025 mM and 0.456± 0.033 mM respectively, 
compared to A. tormentorii, A. purpurea (Mauritius), A. lomatophylloides and A. vera, which 
showed lower reducing potencies, ranging from 0.311 to 0.117 mM.  
 
Superoxide dimutase assay 
One unit (U) of activity of SOD is defined as the amount of enzyme needed to exhibit 50% 
dismutation of the superoxide radical. Treatment with 0.1 mg/ml of the Aloes extracts increased 
the SOD activities in the CAD cells (Figure 2). Aloe purpurea and A. tormentorii moderately 
increased the SOD activity by 26.6% and 15.4 % in 1 day-treated differentiated cells and 22.5% 
and 34.3 % in 6 days-treated differentiated cells. For A. vera, a higher increase (31.6 %) was 
observed in 1 day treated differentiated cells as compared to 6 days-treated differentiated cells. 
A low increase in SOD activity, varying from 5.3% to 6.3 % was observed in undifferentiated 
cells for all the Aloe extracts. 
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Neuroprotective activity of Aloe extracts v/s H2O2- induced neurotoxicity in CAD cells  
Using the preconditioning protocol, no significant protection against H2O2-induced 
cytotoxicity was achieved with the Aloe extracts tested (not shown), but using the 
neuroprotection protocol, where the Aloe extracts were present throughout the exposure to 
H2O2, dose-dependent neuroprotection was observed. Interestingly, the A. macra extract 
elicited a significant delayed cytotoxicity (not observed at 24h, Figure 3b) over the extended 
48 h period, which is comparable to the level of cytotoxicity elicited by 24h H2O2 alone (Figure 
3), and neuroprotection was not observed (0.01 and 0.1 mg/ml). In contrast, the other Aloe 
extracts elicited differential significant levels of neuroprotection (Figure 4), ranging from 30-
97%.  
 
Discussion 
Ever since Mauritius has been colonized, many exotic plants have been used for their various 
medicinal properties. Surveys have revealed that indigenous and endemic species have 
gradually started to become incorporated in the Mauritian Pharmacopeia for various uses. 
Mascarene Islands harbour a rich angiosperm flora with Mauritius leading with 273 out of 691 
being single island endemics and 150 being Mascarene endemics (Baider et al., 2016). Several 
studies have been carried out to evaluate the antioxidant potential of Aloe species. A. ferox, a 
species indigenous to southern Africa has been reported to have an EC50 of 10 μg/ml (Fawole 
et al., 2010) and 86 μg/ml (Wintola, et al., 2011) for methanol extracts in the DPPH assay. In 
a study carried out by Yoo et al., (2008), A. saponaria (Aiton) Haw. (a synonym for A. 
maculata subsp. maculata) exhibited a potential radical scavenging activity with an IC50 value 
of 85 μg/ml. The leaf gel of A. greatheadii var. davyana, native to South Africa has also been 
shown to exhibit antioxidant activities (Loots et al., 2007). Furthermore, Asamenew et al., 
(2011) reported the antioxidant activity of the latex from A. harlana Reynolds and its two 
constituents; an anthrone (aloin) and a chromone (7‐O‐ methylaloeresin A). According to a 
report by Tian and Hua, (2005), aloin and aloe-emodin which are major components in some 
Aloe species exhibited antioxidant or pro-oxidant effects on plasmid DNA.  
 
In this study, three different antioxidant assays, which included evaluation for neuroprotection, 
were used in order to provide a comprehensive prediction of the antioxidant efficacy of the 
tested Aloe extracts, primarily because the mechanism of action of naturally occurring anti-
oxidants can be diverse. The results revealed that all the Aloe species investigated displayed 
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significant free radical scavenging and reducing activities with a similar range of potencies 
(Table 2). As aloin has been previously reported for its antioxidant activity (Tian and Hua, 
2005), the high aloin content in A. purpurea (Réunion) may account for the high antioxidant 
potency observed and possible synergistic effect with other phytochemicals is not to be 
excluded. SOD being an effective defence against ROS- mediated oxidative damage, catalyses 
the dismutation of the superoxide anion (O2
-) into hydrogen peroxide (H2O2) that can be 
degraded into H2O and O2 by catalase. We evaluated the influence of the selected Aloes extracts 
on the level of serum SOD activity in CAD cells. All samples (0.1 mg/ml) increase the SOD 
activity in the CAD with highest rises in 1 day treated differentiated cells for A. purpurea and 
A. tormentorii and in 6 days treated differentiated cells for A. vera. The differences of activity 
among the different Mauritian Aloes are probably due to their different antioxidative 
mechanisms. A study carried by El-Shemy et al., (2009) has revealed a significant increase in 
serum SOD activity of EAC tumor-transplanted experimental animals, in response to the A. 
vera isolated compounds barbaloin, aloe-emodin and aloesin. Yu et al., (2009) reported that A. 
vera polysaccharides are effective at enhancing SOD activity in the plasma and 
polysaccharides present in A. vera have been associated with many of phytotherapeutic 
properties (Grace et al., 2013; Reynolds and Dweck, 1999; Ni and Tizard, 2004) Henceforth, 
it can be hypothesised that along with aloin, there are probably other constituents such as 
polysaccharides and flavonoids acting synergistically to exhibit the elevated SOD activity in 
the neuronal cells. Our results further support the view that the medicinal Aloes are promising 
sources of potential antioxidants. 
 
Interestingly, despite this similarity in antioxidant potency, the Aloe species displayed a marked 
variation in their neuroprotective properties with A. vera and A. lomatophylloides being the 
most and least effective, respectively, which correlated with having the highest and lowest 
aloin: vitexin ratio (Table 1). A. vera, in which the lowest vitexin concentration was observed 
compared to the other species investigated, displayed the most potent neuroprotective effect in 
this study. It is, therefore, postulated that the neuroprotection observed could be due to the 
presence of other chemical constituents. A range of phytochemicals from various other plant 
species have been associated with antioxidant properties and are suggested to modulate factors 
associated with neurodegeneration. These have been investigated for their effects on cognitive 
functions and mechanisms associated with dementia pathology. Such phytochemicals are 
chemically diverse and evidence to support their therapeutic relevance for CNS disorders is 
variable, although emerging data are promising (Williams et al., 2011). It is in this context that 
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we report and compare the antioxidant and neuroprotective potency of the selected Mascarene 
Aloes.  
 
Earlier literature described some of the effects of A. vera on neuronal activity. Wang et al., 
(2010) reported that A. vera at a concentration of 10mg/L had protective effects on 
mitochondria integrity of PC12 neuronal cells and rat brain. Parihar et al., (2004) stated that A. 
vera improves antioxidant activity within the hippocampus and cerebral cortex leading to 
improvement of motor and memory behavioural tasks in diabetic mice. Moreover, a recent 
study reported that A. vera leaf (extract) powder possessed significant antioxidant activity anti-
epileptic (Rathor, 2014), consistent with a traditional Aloe use. Since vitexin has previously 
been reported as neuroprotective (Chandrashekara and Shakarad, 2011; Abbasi et al., 2012; 
Yang et al., 2014), the low concentration detected in A. vera (compared to the other Aloe 
species) suggests that other constituents of A. vera may also be important to mediate the 
neuroprotective effects. Furthermore, with the exception of A. vera, there are limited published 
data on the chemical constituents of the studied Aloe species; thus this study reports novel 
chemical data for these species, which may be correlated with their pharmacological profiles. 
It should also be noted that from a conservation perspective, the discovery that A. vera showed 
the highest potency for neuroprotection is of particular relevance to investigate further for its 
pharmacological potential for neurodegenerative diseases, since this species is not regulated by 
CITES (2015).  
 
In this study, A. tormentorii and A. purpurea (Mauritius) Réunion also showed neuroprotective 
characteristics, ranging from approximately 59.6 % to 74%, representing a promising source 
of compounds with potential relevance for use in a range of neurological diseases (Table A.1). 
Interestingly, A. macra displayed the most notable differences in the observed pharmacological 
properties, including delayed cytotoxic effects and no detectable neuroprotection across the 
range of concentrations tested (0.001, 0.01, 0.01 and 0.1 mg/ml). A. macra and A. vera are 
often misidentified in the field and, subsequently, may be traded or used interchangeably by 
some cosmetic companies in their products. These present results highlight the importance of 
correct identification of medicinal plants as these species clearly display very different 
neuropharmacological effects, with A. macra being potentially hazardous.  
 
Ranghoo-Sanmukhiya et al., (2010) reported that A. tormentorii and A. purpurea from 
Mauritius were richer in anthraquinones than A. macra and that A. vera was almost four-fold 
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richer in anthraquinones than other Mascarene Aloe species. Vitexin was not detected in any 
of the Mascarene Aloe species in the latter study. Differences in chemical components between 
the previous report and this study may be due to many factors such as the site of plant 
collection, environmental factors during cultivation, age of the plants and the extraction 
protocols. A. tormentorii and A. purpurea (Mauritius and Réunion) elicited differential 
significant levels of neuroprotection with a percentage of 74.0, 58.3 and 59.6 respectively. The 
evaluation of the aloin content revealed that A. purpurea from Réunion Island is three-fold 
richer in aloin compared to the other Aloes studied.  
 
Conclusion 
 
This study demonstrated that the endemic Mascarene Aloes (Aloe lomatophylloides, A. macra, 
A. purpurea and A. tormentorii) possess antioxidant and significant neuroprotective activities, 
all of which may be of relevance for the development of new neurodegenerative disease 
therapeutics. HPLC results from the above study confirmed the presence of aloin and which is 
a major compound reported in many Aloes. However as Aloes are well known for harbouring 
other important phytochemicals, it can be postulated that along with aloin and vitexin, there 
could be other constituents acting synergistically to exhibit the potent bioactivity of these 
Mascarene Aloes.  Future research will endeavour at elucidating these phytochemicals. 
However, a sustainable source of these threatened endemics is critical for further 
pharmacological studies. The use of plants for medicinal applications must therefore be 
underpinned by scientific evidence for their use without undermining the conservation of 
biodiversity. 
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Table 1:  Aloin and Vitexin content of Aloe species from the Mascarene Islands 
Species Aloin (nmol/g) Vitexin (nmol/g) 
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A. purpurea (Mauritius) 182.2 
 
27.6 
A. tormentorii 
195.9 67.3 
A. lomatophylloides 
60.0 38.6 
A. macra 
nd 61.7 
A. purpurea (Réunion) 
546.6 54.0 
A. vera 170.2 12.6 
nd: not detected  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Antioxidant capacity of Aloe extracts measured Trolox and copper scavenging 
equivalents 
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Samples  Trolox equivalent 
(mM) 
Copper-reducing 
equivalents(µM) 
 
Standard  
(Trolox) (Vitamin A) 
A. purpurea (Mauritius)  0.430 ± 0.049 0.295 ± 0.044 
A. tormentorii  0.380 ± 0.030 0.311 ± 0.017 
A. lomatophylloides  0.440 ± 0.027 0.255 ± 0.013 
A. macra  0.360 ± 0.044 0.456 ± 0.033 
A. purpurea (Réunion)  0.350 ± 0.033 0.643 ± 0.025 
A. vera  0.550 ± 0.097 0.177 ± 0.021 
 
